Skip to main content
Publications
Castellsague J, Calingaert B, Rothman KJ, Gutierrez L, van Herk-Sukel MPP, Kuiper JG, Pottegard A, Hallas J, Berglind IA, Sundstrom A, Dedman D, Gallagher A, Kaye JA, Pardo C, Perez-Gutthann S. Probabilistic bias analysis for unmeasured confounders in a study of users of topical tacrolimus, pimecrolimus, and corticosteroids (JOELLE) study. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):142-3.
Castellsague J, Kuiper JJG, Pottegard A, Berglind IA, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MPP, Hallas J, Sundstrom A, Gallagher A, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S. Risk of lymphoma in users of topical tacrolimus, pimecrolimus and corticosteroids (JOELLE study). Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):494-5.
Castellsague J, van Herk-Sukel MPP, Hallas J, Sundstrom A, Gallagher A, Gutierrez L, Calingaert B, Kuiper JG, Pottegard A, Berglind IA, Dedman D, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S. Risk of skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids. JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):527.
Stenehjem DD, Tyczynski J, Unni SK, Bauer H, Sainski A, Deka R, Schauerhamer M, Tak C, Ma J, Gutierrez L, Kaye JA, Telford C, Brixner DI, Biskupiak JE. Increasing BRCA testing in breast cancer patients at a NCI designated Comprehensive Cancer Center. Poster presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer; May 2016. Montreal, Canada.
Stenehjem DD, Telford C, Unni SK, Bauer H, Sainski A, Deka R, Schauerhamer M, Ye X, Tak C, Ma J, Gutierrez L, Kaye JA, Tyczynski J, Brixner DI, Biskupiak JE. Utilization of neoadjuvant chemotherapy in women with breast cancer tested for BRCA mutations at a NCI designated Comprehensive Cancer Center. Poster presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer; May 2016. Montreal, Canada.